Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
Rhea-AI Summary
Theratechnologies (TSX: TH) (NASDAQ: THTX), a specialty biopharmaceutical company, has scheduled its fourth quarter and full year fiscal 2024 financial results announcement and business update for February 26, 2025, at 8:30 a.m. ET.
The conference call will be led by Paul Lévesque, President and CEO, alongside other key management team members including Philippe Dubuc (CFO), Christian Marsolais (CMO), and John Leasure (Global Commercial Officer). The team will present prepared remarks followed by a Q&A session.
Participants are advised to join the call ten minutes before start time. The presentation will be accessible via webcast and telephone conference, with replay options available until March 5, 2025.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, THTX gained 7.36%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
MONTREAL, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care, today announced the Company will report financial results and provide a business update for its fourth quarter and full year fiscal 2024 ended November 30 on Wednesday, February 26, 2025, at 8:30 a.m. ET.
The call will be hosted by Paul Lévesque, President and Chief Executive Officer, who will be joined by other members of the management team, including Philippe Dubuc, Senior Vice President and Chief Financial Officer, Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer and John Leasure, Global Commercial Officer. They will be available to answer questions from participants following prepared remarks.
Participants are encouraged to join the call at least ten minutes in advance to secure access. Conference call dial-in and replay information can be found below.
| CONFERENCE CALL INFORMATION | |
| Conference Call Date | February 26, 2025 |
| Conference Call Time | 8:30 a.m. ET |
| Webcast link | https://edge.media-server.com/mmc/p/2h9ningt |
| Dial in | 1-888-513-4119 (toll free) or 1-412-902-6615 (international) |
| Access Code | 4430181 |
| CONFERENCE CALL REPLAY | |
| Toll Free | 1-877-344-7529 (US) / 1-855-669-9658 (Canada) |
| International Toll | 1-412-317-0088 |
| Replay Access Code | 3856571 |
| Replay End Date | March 5, 2025 |
| To access the replay using an international dial-in number, please select this link: https://services.choruscall.com/ccforms/replay.html | |
An archived webcast will also be available on the Company’s Investor Relations website under ‘Past Events’.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X.
Contacts:
Investor inquiries:
Joanne Choi
Senior Director, Investor Relations
jchoi@theratech.com
1-551-261-0401
Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
1-514-336-7800
FAQ
When will Theratechnologies (THTX) release its Q4 and FY 2024 earnings?
How can investors access THTX's Q4 2024 earnings call?
Who will be presenting at Theratechnologies' Q4 2024 earnings call?
Until when will THTX's Q4 2024 earnings call replay be available?
